FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 9:45 AM ISTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
Bristol-Myers posts strong second quarter as Eliquis, Orencia sales propel Medical Dialogues Bureau28 July 2019 9:17 AM ISTSales of Eliquis, which Bristol-Myers shares with Pfizer Inc (PFE.N), rose 24% to $2.04 billion, while Orencia sales rose 9% to $778 million, both...
Pfizer gets USFDA approval for Fragmin to treat blood clot in pediatric patients Farhat Nasim19 May 2019 9:45 AM ISTThe efficacy of Fragmin in children was based on a single trial with 38 pediatric patients with symptomatic deep vein thrombosis and/or pulmonary...
Vaccine and blood thinner help drive Pfizer to quarterly earnings beat Medical Dialogues Bureau1 May 2019 12:07 PM ISTPfizer Inc on Tuesday reported a first-quarter profit that beat Wall Street estimates and slightly raised its 2019 earnings forecast, as the company...
JnJ, Bayer settles Xarelto lawsuits for 775 million Dollar Farhat Nasim27 March 2019 12:24 PM ISTLawsuits over Xarelto began piling up in 2014 and the companies had so far won all six trials over Xarelto's alleged bleeding risk.U.S: Bayer AG and...
France fines Johnson and Johnson 29.6 million dollars over painkiller patch Ruby Khatun Khatun21 Dec 2017 10:15 AM ISTPARIS: France's competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros ($29.6 million) on Wednesday after it ruled...
Delhi HC allows Natco, Alembic to Export Rivaroxaban of Bayer savita thakur thakur10 March 2017 9:45 AM ISTNEW DELHI: In a recent order passed by Delhi High Court, the court has granted the permission to Indian pharmaceuticals companies, Alembic and Natco...
